Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Cells, Circulating | 30 | 2016 | 933 | 5.260 |
Why?
|
Wilms Tumor | 37 | 2015 | 373 | 2.910 |
Why?
|
Genes, Wilms Tumor | 24 | 2007 | 94 | 2.610 |
Why?
|
WT1 Proteins | 25 | 2010 | 178 | 1.790 |
Why?
|
Tumor Suppressor Proteins | 24 | 2015 | 2850 | 1.640 |
Why?
|
Drug Resistance, Neoplasm | 21 | 2016 | 5170 | 1.490 |
Why?
|
Genes, BRCA1 | 12 | 2006 | 781 | 1.280 |
Why?
|
Genes, Tumor Suppressor | 19 | 2010 | 1097 | 1.250 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 25 | 2015 | 5230 | 1.250 |
Why?
|
DNA, Neoplasm | 11 | 2015 | 1758 | 1.240 |
Why?
|
Transcription Factors | 36 | 2015 | 12209 | 1.220 |
Why?
|
Quinazolines | 18 | 2015 | 1356 | 1.180 |
Why?
|
Epithelial-Mesenchymal Transition | 8 | 2016 | 713 | 1.140 |
Why?
|
Mutation | 63 | 2016 | 29777 | 1.090 |
Why?
|
Germ-Line Mutation | 20 | 2007 | 1787 | 1.040 |
Why?
|
DNA-Binding Proteins | 40 | 2011 | 9648 | 1.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 29 | 2015 | 8430 | 1.000 |
Why?
|
Lung Neoplasms | 33 | 2015 | 13112 | 1.000 |
Why?
|
Breast Neoplasms | 41 | 2016 | 20827 | 0.980 |
Why?
|
DNA, Satellite | 2 | 2015 | 69 | 0.920 |
Why?
|
Zinc Fingers | 12 | 2010 | 583 | 0.920 |
Why?
|
Cell Separation | 12 | 2015 | 1750 | 0.910 |
Why?
|
Tumor Cells, Cultured | 36 | 2015 | 6311 | 0.880 |
Why?
|
Mammary Neoplasms, Experimental | 3 | 2015 | 520 | 0.870 |
Why?
|
Neoplasm Metastasis | 9 | 2015 | 4848 | 0.830 |
Why?
|
Protein Kinase Inhibitors | 20 | 2015 | 5532 | 0.790 |
Why?
|
Cell Line, Tumor | 49 | 2016 | 16674 | 0.790 |
Why?
|
Neoplasms | 31 | 2016 | 21675 | 0.780 |
Why?
|
Antineoplastic Agents | 31 | 2016 | 13691 | 0.730 |
Why?
|
Oncogenes | 12 | 2016 | 1265 | 0.730 |
Why?
|
Transcriptional Activation | 11 | 2015 | 1783 | 0.710 |
Why?
|
Wnt Proteins | 2 | 2015 | 721 | 0.710 |
Why?
|
Tumor Suppressor Protein p53 | 11 | 2015 | 2944 | 0.700 |
Why?
|
Kidney Neoplasms | 24 | 2015 | 4260 | 0.700 |
Why?
|
Gene Amplification | 9 | 2011 | 1063 | 0.680 |
Why?
|
Sequence Deletion | 14 | 2013 | 1524 | 0.670 |
Why?
|
Chromosomes, Human, Pair 11 | 14 | 2006 | 417 | 0.670 |
Why?
|
Intracellular Signaling Peptides and Proteins | 9 | 2012 | 2914 | 0.630 |
Why?
|
Adaptor Proteins, Signal Transducing | 10 | 2015 | 2916 | 0.620 |
Why?
|
Receptors, Androgen | 2 | 2015 | 1055 | 0.610 |
Why?
|
Nuclear Proteins | 10 | 2015 | 5854 | 0.600 |
Why?
|
Genes, erbB-1 | 3 | 2008 | 161 | 0.600 |
Why?
|
Repressor Proteins | 7 | 2015 | 3024 | 0.590 |
Why?
|
Cell Transformation, Neoplastic | 13 | 2010 | 2942 | 0.590 |
Why?
|
Pancreatic Neoplasms | 6 | 2016 | 5264 | 0.590 |
Why?
|
Microfluidic Analytical Techniques | 9 | 2015 | 828 | 0.590 |
Why?
|
Insulin-Like Growth Factor II | 3 | 2013 | 272 | 0.580 |
Why?
|
Point Mutation | 7 | 2007 | 1623 | 0.580 |
Why?
|
Drosophila Proteins | 6 | 2009 | 1709 | 0.580 |
Why?
|
DNA Mutational Analysis | 23 | 2010 | 4183 | 0.570 |
Why?
|
BRCA2 Protein | 9 | 2008 | 794 | 0.570 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2012 | 1581 | 0.550 |
Why?
|
rap GTP-Binding Proteins | 2 | 2007 | 28 | 0.530 |
Why?
|
Cell Movement | 9 | 2016 | 5216 | 0.530 |
Why?
|
Molecular Sequence Data | 43 | 2012 | 18107 | 0.530 |
Why?
|
RNA Interference | 6 | 2014 | 2890 | 0.530 |
Why?
|
Centromere | 2 | 2015 | 220 | 0.500 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.500 |
Why?
|
Kidney | 17 | 2010 | 7185 | 0.500 |
Why?
|
Animals | 88 | 2016 | 168660 | 0.490 |
Why?
|
SUMO-1 Protein | 2 | 2004 | 35 | 0.490 |
Why?
|
Promoter Regions, Genetic | 15 | 2015 | 5867 | 0.490 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2009 | 1678 | 0.480 |
Why?
|
Phenylthiohydantoin | 1 | 2015 | 193 | 0.480 |
Why?
|
Notochord | 1 | 2013 | 36 | 0.470 |
Why?
|
Protein Kinases | 7 | 2009 | 1640 | 0.470 |
Why?
|
Trans-Activators | 7 | 2009 | 2927 | 0.470 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 2015 | 798 | 0.470 |
Why?
|
RNA Processing, Post-Transcriptional | 3 | 2007 | 436 | 0.470 |
Why?
|
Genes, Neoplasm | 4 | 2012 | 376 | 0.460 |
Why?
|
Protein-Tyrosine Kinases | 7 | 2010 | 2453 | 0.450 |
Why?
|
Base Sequence | 34 | 2010 | 12798 | 0.450 |
Why?
|
Genes, p53 | 9 | 2001 | 755 | 0.450 |
Why?
|
SOXB1 Transcription Factors | 1 | 2015 | 284 | 0.450 |
Why?
|
Humans | 224 | 2016 | 743811 | 0.450 |
Why?
|
Introns | 3 | 2013 | 991 | 0.430 |
Why?
|
Neoplasm Proteins | 10 | 2013 | 3706 | 0.410 |
Why?
|
RNA, Neoplasm | 7 | 2013 | 769 | 0.410 |
Why?
|
Mice | 51 | 2016 | 81154 | 0.410 |
Why?
|
Neoplasms, Hormone-Dependent | 2 | 2012 | 413 | 0.400 |
Why?
|
Drug Substitution | 1 | 2014 | 281 | 0.400 |
Why?
|
Protein Processing, Post-Translational | 2 | 2013 | 1986 | 0.400 |
Why?
|
Cell Survival | 8 | 2015 | 5881 | 0.390 |
Why?
|
p300-CBP Transcription Factors | 1 | 2012 | 147 | 0.380 |
Why?
|
MicroRNAs | 4 | 2015 | 3750 | 0.380 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 602 | 0.380 |
Why?
|
Heterozygote | 11 | 2008 | 2803 | 0.380 |
Why?
|
Osteosarcoma | 10 | 2015 | 881 | 0.380 |
Why?
|
Genes, BRCA2 | 3 | 2003 | 618 | 0.370 |
Why?
|
Glycoproteins | 4 | 2009 | 2266 | 0.370 |
Why?
|
Chordoma | 1 | 2013 | 359 | 0.370 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2010 | 205 | 0.370 |
Why?
|
RNA Splicing | 7 | 2015 | 907 | 0.360 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2009 | 443 | 0.360 |
Why?
|
Li-Fraumeni Syndrome | 2 | 2001 | 114 | 0.360 |
Why?
|
Proto-Oncogene Proteins | 7 | 2015 | 4552 | 0.350 |
Why?
|
RNA, Messenger | 22 | 2013 | 13028 | 0.350 |
Why?
|
Proto-Oncogene Proteins c-met | 4 | 2011 | 579 | 0.350 |
Why?
|
Organic Cation Transport Proteins | 1 | 2009 | 52 | 0.350 |
Why?
|
RNA, Untranslated | 3 | 2015 | 452 | 0.350 |
Why?
|
Gene Deletion | 7 | 2010 | 2749 | 0.350 |
Why?
|
Receptor, erbB-2 | 3 | 2016 | 2418 | 0.350 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2013 | 634 | 0.340 |
Why?
|
Epithelial Cells | 7 | 2014 | 3690 | 0.340 |
Why?
|
Immediate-Early Proteins | 3 | 2015 | 453 | 0.340 |
Why?
|
Proteins | 10 | 2002 | 6098 | 0.340 |
Why?
|
Apoptosis | 20 | 2015 | 9718 | 0.340 |
Why?
|
Caenorhabditis elegans Proteins | 3 | 2004 | 852 | 0.340 |
Why?
|
Forkhead Transcription Factors | 2 | 2015 | 1613 | 0.340 |
Why?
|
Sulfones | 2 | 2015 | 434 | 0.330 |
Why?
|
Genes, Homeobox | 3 | 2004 | 286 | 0.330 |
Why?
|
Chromosomes, Human, X | 2 | 2007 | 296 | 0.320 |
Why?
|
Gene Silencing | 5 | 2007 | 1537 | 0.320 |
Why?
|
Phosphoric Monoester Hydrolases | 4 | 2006 | 431 | 0.320 |
Why?
|
Gene Expression Regulation | 12 | 2015 | 12066 | 0.320 |
Why?
|
Microfluidics | 5 | 2015 | 662 | 0.310 |
Why?
|
Embryonic Stem Cells | 2 | 2015 | 1295 | 0.310 |
Why?
|
Membrane Proteins | 8 | 2015 | 7880 | 0.310 |
Why?
|
Genes, vpr | 1 | 2007 | 21 | 0.310 |
Why?
|
Amino Acid Sequence | 24 | 2010 | 13809 | 0.310 |
Why?
|
Cell Line | 17 | 2015 | 15993 | 0.310 |
Why?
|
Prostatic Neoplasms | 11 | 2015 | 11059 | 0.310 |
Why?
|
Biomedical Research | 2 | 2015 | 3308 | 0.310 |
Why?
|
Sequence Analysis, RNA | 6 | 2015 | 2009 | 0.310 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2007 | 55 | 0.310 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2008 | 91 | 0.310 |
Why?
|
Chromatin | 3 | 2015 | 2931 | 0.300 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2008 | 190 | 0.300 |
Why?
|
Carcinoma, Small Cell | 3 | 2008 | 420 | 0.290 |
Why?
|
Forecasting | 2 | 2015 | 2950 | 0.290 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 1691 | 0.290 |
Why?
|
Phosphoproteins | 3 | 2006 | 2440 | 0.290 |
Why?
|
Ceramides | 1 | 2008 | 199 | 0.290 |
Why?
|
Androgen Antagonists | 1 | 2015 | 1376 | 0.280 |
Why?
|
Cell Cycle Proteins | 12 | 2011 | 3463 | 0.280 |
Why?
|
Leukemia | 4 | 2008 | 1509 | 0.280 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1743 | 0.280 |
Why?
|
Medical Oncology | 2 | 2015 | 2267 | 0.280 |
Why?
|
Ubiquitin-Conjugating Enzymes | 2 | 2004 | 195 | 0.280 |
Why?
|
Transcription, Genetic | 16 | 2013 | 7719 | 0.280 |
Why?
|
Molecular Targeted Therapy | 2 | 2015 | 2727 | 0.280 |
Why?
|
Receptors, Growth Factor | 2 | 2010 | 334 | 0.270 |
Why?
|
Carrier Proteins | 6 | 2014 | 5021 | 0.270 |
Why?
|
Evolution, Molecular | 5 | 2008 | 1940 | 0.270 |
Why?
|
Disease Models, Animal | 8 | 2014 | 18027 | 0.260 |
Why?
|
Quinolines | 2 | 2008 | 732 | 0.260 |
Why?
|
Indoles | 6 | 2015 | 1841 | 0.260 |
Why?
|
Homeodomain Proteins | 3 | 2011 | 2419 | 0.260 |
Why?
|
Genes, Regulator | 2 | 2003 | 379 | 0.260 |
Why?
|
Drug Resistance | 4 | 2005 | 1606 | 0.260 |
Why?
|
RNA, Small Interfering | 9 | 2015 | 3504 | 0.260 |
Why?
|
Neural Crest | 1 | 2007 | 275 | 0.260 |
Why?
|
BRCA1 Protein | 7 | 2004 | 1148 | 0.250 |
Why?
|
Milk Proteins | 2 | 2004 | 167 | 0.250 |
Why?
|
Oligonucleotide Array Sequence Analysis | 9 | 2010 | 3917 | 0.250 |
Why?
|
Signal Transduction | 16 | 2016 | 23398 | 0.250 |
Why?
|
Transfection | 15 | 2009 | 5892 | 0.250 |
Why?
|
Eukaryotic Cells | 2 | 2003 | 198 | 0.250 |
Why?
|
Female | 87 | 2016 | 380020 | 0.250 |
Why?
|
Loss of Heterozygosity | 4 | 2002 | 684 | 0.240 |
Why?
|
Jews | 5 | 2004 | 385 | 0.240 |
Why?
|
RNA-Binding Protein EWS | 5 | 2012 | 216 | 0.240 |
Why?
|
Ribonucleoproteins | 2 | 1997 | 380 | 0.240 |
Why?
|
Acetylation | 3 | 2013 | 1084 | 0.230 |
Why?
|
Proto-Oncogene Proteins B-raf | 5 | 2015 | 2039 | 0.230 |
Why?
|
Disease Progression | 7 | 2013 | 13273 | 0.230 |
Why?
|
Cell Nucleus | 5 | 2013 | 2969 | 0.230 |
Why?
|
Gene Expression Profiling | 9 | 2012 | 9440 | 0.230 |
Why?
|
Morphogenesis | 1 | 2007 | 751 | 0.230 |
Why?
|
Polymorphism, Genetic | 6 | 2008 | 4326 | 0.230 |
Why?
|
Zebrafish | 2 | 2014 | 2995 | 0.220 |
Why?
|
Cell Proliferation | 7 | 2016 | 10477 | 0.220 |
Why?
|
Gene Knockdown Techniques | 4 | 2015 | 1656 | 0.220 |
Why?
|
Genetic Markers | 8 | 2012 | 2634 | 0.220 |
Why?
|
X Chromosome | 4 | 2001 | 814 | 0.210 |
Why?
|
Pregnancy Proteins | 1 | 2003 | 229 | 0.210 |
Why?
|
Capillaries | 2 | 2016 | 773 | 0.210 |
Why?
|
Lymphoproliferative Disorders | 4 | 2001 | 524 | 0.210 |
Why?
|
Alginates | 2 | 2015 | 252 | 0.210 |
Why?
|
Drug Monitoring | 1 | 2008 | 953 | 0.210 |
Why?
|
Cell Adhesion | 2 | 2014 | 3144 | 0.210 |
Why?
|
Protein Tyrosine Phosphatases | 3 | 1998 | 473 | 0.200 |
Why?
|
Glioblastoma | 3 | 2014 | 3480 | 0.200 |
Why?
|
Immunoblotting | 5 | 2009 | 1683 | 0.200 |
Why?
|
Cytosine | 1 | 2003 | 216 | 0.200 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2014 | 729 | 0.200 |
Why?
|
Estrogens | 2 | 2008 | 1563 | 0.200 |
Why?
|
Neoplastic Stem Cells | 1 | 2010 | 1376 | 0.200 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2010 | 705 | 0.200 |
Why?
|
DNA Damage | 5 | 2011 | 2429 | 0.200 |
Why?
|
Mutation, Missense | 6 | 2009 | 2566 | 0.200 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2016 | 3547 | 0.200 |
Why?
|
Phosphorylation | 9 | 2013 | 8436 | 0.190 |
Why?
|
Up-Regulation | 5 | 2009 | 4221 | 0.190 |
Why?
|
Alleles | 11 | 2007 | 6934 | 0.190 |
Why?
|
Exocytosis | 1 | 2002 | 354 | 0.190 |
Why?
|
Genome, Human | 3 | 2012 | 4418 | 0.190 |
Why?
|
Ovarian Neoplasms | 6 | 2011 | 4839 | 0.190 |
Why?
|
Zebrafish Proteins | 1 | 2007 | 1005 | 0.190 |
Why?
|
Genetic Testing | 9 | 2007 | 3439 | 0.190 |
Why?
|
Stomach Neoplasms | 2 | 2011 | 1332 | 0.190 |
Why?
|
Gene Expression | 11 | 2014 | 7793 | 0.190 |
Why?
|
Receptors, Interleukin | 1 | 2002 | 245 | 0.190 |
Why?
|
Growth Substances | 2 | 2001 | 784 | 0.190 |
Why?
|
Sialoglycoproteins | 1 | 2001 | 318 | 0.190 |
Why?
|
Ovariectomy | 2 | 2003 | 661 | 0.190 |
Why?
|
Drosophila melanogaster | 1 | 2009 | 1712 | 0.180 |
Why?
|
Alternative Splicing | 6 | 2010 | 1117 | 0.180 |
Why?
|
Tamoxifen | 4 | 2014 | 981 | 0.180 |
Why?
|
Blotting, Northern | 9 | 2004 | 1581 | 0.180 |
Why?
|
Neoplasm Transplantation | 5 | 2014 | 2085 | 0.180 |
Why?
|
Nanostructures | 2 | 2015 | 552 | 0.180 |
Why?
|
Xenopus Proteins | 1 | 2002 | 432 | 0.180 |
Why?
|
Animals, Genetically Modified | 3 | 2013 | 1552 | 0.180 |
Why?
|
Genetic Predisposition to Disease | 13 | 2015 | 17439 | 0.180 |
Why?
|
Oncogene Proteins | 2 | 2006 | 749 | 0.180 |
Why?
|
G2 Phase | 1 | 1999 | 139 | 0.170 |
Why?
|
GTPase-Activating Proteins | 1 | 2003 | 498 | 0.170 |
Why?
|
Sequence Analysis, DNA | 5 | 2014 | 4803 | 0.170 |
Why?
|
G1 Phase | 2 | 1999 | 415 | 0.170 |
Why?
|
Genotype | 11 | 2015 | 12944 | 0.170 |
Why?
|
Endopeptidases | 1 | 2003 | 772 | 0.170 |
Why?
|
Melanoma | 6 | 2015 | 5508 | 0.170 |
Why?
|
Genetic Diseases, Inborn | 2 | 2003 | 588 | 0.170 |
Why?
|
Male | 64 | 2015 | 349776 | 0.170 |
Why?
|
Breast | 1 | 2008 | 1970 | 0.170 |
Why?
|
Cell Cycle | 7 | 2015 | 2963 | 0.170 |
Why?
|
Translocation, Genetic | 3 | 2008 | 1420 | 0.170 |
Why?
|
Binding Sites | 7 | 2008 | 6111 | 0.160 |
Why?
|
Telomere | 2 | 2015 | 910 | 0.160 |
Why?
|
src Homology Domains | 2 | 2001 | 364 | 0.160 |
Why?
|
Adenovirus E1B Proteins | 1 | 1998 | 15 | 0.160 |
Why?
|
Chromosome Deletion | 6 | 2007 | 1396 | 0.160 |
Why?
|
Therapeutics | 2 | 2013 | 116 | 0.160 |
Why?
|
Protein Isoforms | 3 | 2010 | 1729 | 0.160 |
Why?
|
RNA-Binding Proteins | 2 | 2005 | 1900 | 0.160 |
Why?
|
In Situ Hybridization, Fluorescence | 7 | 2010 | 2649 | 0.160 |
Why?
|
Nucleic Acid Hybridization | 4 | 2015 | 1374 | 0.160 |
Why?
|
Mesoderm | 3 | 2013 | 686 | 0.160 |
Why?
|
Gene Frequency | 4 | 2014 | 3585 | 0.160 |
Why?
|
Cell Aggregation | 2 | 2016 | 244 | 0.160 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 494 | 0.150 |
Why?
|
Genes, Dominant | 6 | 1995 | 880 | 0.150 |
Why?
|
Caenorhabditis elegans | 5 | 2004 | 1417 | 0.150 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2010 | 4749 | 0.150 |
Why?
|
Mice, Nude | 5 | 2015 | 3680 | 0.150 |
Why?
|
Symporters | 1 | 2000 | 362 | 0.150 |
Why?
|
Lamin Type B | 1 | 2016 | 25 | 0.150 |
Why?
|
Cell Culture Techniques | 2 | 2015 | 1677 | 0.150 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2009 | 625 | 0.140 |
Why?
|
Biological Evolution | 1 | 2003 | 1079 | 0.140 |
Why?
|
Drug Delivery Systems | 3 | 2016 | 2217 | 0.140 |
Why?
|
Growth Inhibitors | 1 | 1998 | 385 | 0.140 |
Why?
|
Iodine Radioisotopes | 1 | 2000 | 1035 | 0.140 |
Why?
|
Mammary Glands, Human | 2 | 2009 | 199 | 0.140 |
Why?
|
Ficoll | 1 | 2016 | 40 | 0.140 |
Why?
|
PTEN Phosphohydrolase | 4 | 2014 | 1142 | 0.140 |
Why?
|
Microarray Analysis | 2 | 2010 | 765 | 0.140 |
Why?
|
Adenocarcinoma | 7 | 2016 | 6363 | 0.140 |
Why?
|
Pedigree | 9 | 2007 | 4643 | 0.130 |
Why?
|
Pyridines | 3 | 2013 | 2827 | 0.130 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1998 | 403 | 0.130 |
Why?
|
In Situ Hybridization | 6 | 2004 | 1952 | 0.130 |
Why?
|
Stromal Cells | 3 | 2014 | 1356 | 0.130 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 1998 | 241 | 0.130 |
Why?
|
Brain Neoplasms | 3 | 2014 | 8856 | 0.130 |
Why?
|
Phenotype | 7 | 2016 | 16361 | 0.130 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 1995 | 64 | 0.130 |
Why?
|
Enzyme Inhibitors | 2 | 2006 | 3794 | 0.130 |
Why?
|
Khellin | 1 | 2014 | 5 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2004 | 1284 | 0.130 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2015 | 180 | 0.130 |
Why?
|
Blood Preservation | 1 | 2016 | 177 | 0.130 |
Why?
|
Malate Dehydrogenase | 1 | 2014 | 41 | 0.130 |
Why?
|
Osteonectin | 1 | 2014 | 34 | 0.130 |
Why?
|
Reactive Oxygen Species | 1 | 2002 | 2077 | 0.130 |
Why?
|
Phthalazines | 2 | 2014 | 359 | 0.130 |
Why?
|
Neoplasms, Second Primary | 2 | 2000 | 1063 | 0.130 |
Why?
|
Precipitin Tests | 3 | 2002 | 829 | 0.130 |
Why?
|
Gene Expression Regulation, Developmental | 6 | 2010 | 3622 | 0.120 |
Why?
|
Retinal Dehydrogenase | 1 | 2014 | 74 | 0.120 |
Why?
|
Cyclins | 1 | 1997 | 603 | 0.120 |
Why?
|
Bone Neoplasms | 3 | 2014 | 2529 | 0.120 |
Why?
|
DNA | 5 | 2003 | 7295 | 0.120 |
Why?
|
Oncogene Proteins, Viral | 2 | 1995 | 362 | 0.120 |
Why?
|
Genomics | 4 | 2012 | 5714 | 0.120 |
Why?
|
Genomic Instability | 2 | 2016 | 695 | 0.120 |
Why?
|
WAGR Syndrome | 1 | 1993 | 3 | 0.120 |
Why?
|
Age of Onset | 7 | 2007 | 3268 | 0.120 |
Why?
|
Organ Specificity | 3 | 2013 | 2008 | 0.120 |
Why?
|
Ultraviolet Rays | 2 | 2012 | 1060 | 0.110 |
Why?
|
Sequence Homology, Amino Acid | 6 | 2003 | 2839 | 0.110 |
Why?
|
Mice, Inbred NOD | 2 | 2015 | 1876 | 0.110 |
Why?
|
Predictive Value of Tests | 7 | 2015 | 15067 | 0.110 |
Why?
|
Receptor, Notch1 | 1 | 2016 | 502 | 0.110 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 1993 | 197 | 0.110 |
Why?
|
Protein Structure, Tertiary | 7 | 2006 | 3847 | 0.110 |
Why?
|
Chromosome Mapping | 12 | 2000 | 4737 | 0.110 |
Why?
|
Metalloproteins | 2 | 1990 | 100 | 0.110 |
Why?
|
Colonic Neoplasms | 4 | 2012 | 2542 | 0.110 |
Why?
|
Hepatoblastoma | 1 | 2013 | 87 | 0.110 |
Why?
|
Cell Line, Transformed | 3 | 2001 | 897 | 0.110 |
Why?
|
RNA | 5 | 2015 | 2748 | 0.110 |
Why?
|
Wnt2 Protein | 1 | 2012 | 28 | 0.110 |
Why?
|
Cyclin-Dependent Kinases | 1 | 1996 | 671 | 0.110 |
Why?
|
Contact Inhibition | 1 | 2012 | 48 | 0.110 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2013 | 102 | 0.110 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2016 | 644 | 0.110 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2016 | 1637 | 0.110 |
Why?
|
5' Untranslated Regions | 1 | 2013 | 249 | 0.110 |
Why?
|
Models, Biological | 6 | 2014 | 9582 | 0.110 |
Why?
|
Genome-Wide Association Study | 2 | 2010 | 12259 | 0.110 |
Why?
|
Adipogenesis | 1 | 2015 | 357 | 0.110 |
Why?
|
Polymorphism, Restriction Fragment Length | 4 | 2000 | 769 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 2 | 2003 | 3389 | 0.100 |
Why?
|
Hair Color | 1 | 2012 | 136 | 0.100 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 664 | 0.100 |
Why?
|
Telomerase | 4 | 2015 | 731 | 0.100 |
Why?
|
F-Box Proteins | 2 | 2005 | 196 | 0.100 |
Why?
|
Carcinoma | 1 | 2003 | 2375 | 0.100 |
Why?
|
Retroviridae | 2 | 2007 | 913 | 0.100 |
Why?
|
Cell Growth Processes | 1 | 2012 | 399 | 0.100 |
Why?
|
Mice, Inbred C57BL | 7 | 2014 | 21824 | 0.100 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2014 | 1523 | 0.100 |
Why?
|
Polymerase Chain Reaction | 12 | 2010 | 6170 | 0.100 |
Why?
|
Methylation | 2 | 2013 | 1104 | 0.100 |
Why?
|
Protein Binding | 5 | 2013 | 9377 | 0.100 |
Why?
|
Biopolymers | 1 | 2012 | 189 | 0.100 |
Why?
|
Exons | 8 | 2006 | 2438 | 0.100 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2015 | 671 | 0.100 |
Why?
|
Conserved Sequence | 3 | 2004 | 1202 | 0.100 |
Why?
|
Cell Division | 7 | 2002 | 4568 | 0.100 |
Why?
|
Poly T | 1 | 2010 | 5 | 0.100 |
Why?
|
Frameshift Mutation | 3 | 1997 | 399 | 0.100 |
Why?
|
DEAD-box RNA Helicases | 1 | 2013 | 375 | 0.100 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2012 | 261 | 0.090 |
Why?
|
3T3 Cells | 3 | 2001 | 1102 | 0.090 |
Why?
|
Cell Tracking | 1 | 2012 | 144 | 0.090 |
Why?
|
Rats | 8 | 2001 | 24250 | 0.090 |
Why?
|
Pyrazoles | 2 | 2011 | 1970 | 0.090 |
Why?
|
Melanoma, Experimental | 1 | 2014 | 560 | 0.090 |
Why?
|
Reverse Transcription | 1 | 2010 | 47 | 0.090 |
Why?
|
Diffusion of Innovation | 1 | 2015 | 725 | 0.090 |
Why?
|
Single-Cell Analysis | 3 | 2015 | 2177 | 0.090 |
Why?
|
Skin Pigmentation | 1 | 2012 | 282 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 646 | 0.090 |
Why?
|
Nerve Tissue Proteins | 1 | 2003 | 4463 | 0.090 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2015 | 1157 | 0.090 |
Why?
|
Nitriles | 1 | 2015 | 953 | 0.090 |
Why?
|
Chloramphenicol O-Acetyltransferase | 3 | 1995 | 222 | 0.090 |
Why?
|
Receptors, Invertebrate Peptide | 1 | 2009 | 11 | 0.090 |
Why?
|
Protein Biosynthesis | 5 | 2002 | 2123 | 0.090 |
Why?
|
Immunohistochemistry | 4 | 2015 | 11360 | 0.090 |
Why?
|
Catalysis | 4 | 2007 | 762 | 0.090 |
Why?
|
Culture | 1 | 2014 | 632 | 0.090 |
Why?
|
Estrogen Receptor alpha | 1 | 2014 | 577 | 0.090 |
Why?
|
Cadherins | 1 | 2015 | 907 | 0.090 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 890 | 0.090 |
Why?
|
Lymphocyte Activation | 1 | 2001 | 5524 | 0.090 |
Why?
|
Anilides | 1 | 2013 | 409 | 0.090 |
Why?
|
Protein Stability | 1 | 2012 | 556 | 0.090 |
Why?
|
Cell Shape | 2 | 2013 | 375 | 0.090 |
Why?
|
Terminology as Topic | 1 | 1997 | 1546 | 0.090 |
Why?
|
Drosophila | 3 | 2008 | 1494 | 0.090 |
Why?
|
Models, Genetic | 5 | 2016 | 3492 | 0.090 |
Why?
|
Benzamides | 1 | 2015 | 1383 | 0.090 |
Why?
|
Biocompatible Materials | 2 | 2015 | 1731 | 0.090 |
Why?
|
Models, Cardiovascular | 1 | 2015 | 996 | 0.090 |
Why?
|
Genes, ras | 2 | 2007 | 690 | 0.090 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1999 | 1886 | 0.090 |
Why?
|
Adult | 28 | 2015 | 213889 | 0.090 |
Why?
|
Colony-Forming Units Assay | 2 | 2007 | 355 | 0.090 |
Why?
|
DNA Methylation | 5 | 2016 | 4286 | 0.090 |
Why?
|
DNA Primers | 6 | 2008 | 2891 | 0.090 |
Why?
|
History, 21st Century | 1 | 2015 | 1532 | 0.090 |
Why?
|
Doxorubicin | 2 | 2014 | 2234 | 0.090 |
Why?
|
Neurosecretory Systems | 1 | 2011 | 231 | 0.090 |
Why?
|
Response Elements | 2 | 2002 | 312 | 0.090 |
Why?
|
Esophageal Neoplasms | 2 | 2011 | 1585 | 0.080 |
Why?
|
Zinc | 2 | 1990 | 683 | 0.080 |
Why?
|
Radiation Tolerance | 1 | 2011 | 486 | 0.080 |
Why?
|
DNA Helicases | 3 | 2015 | 861 | 0.080 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 1989 | 322 | 0.080 |
Why?
|
Histone Deacetylases | 1 | 2013 | 727 | 0.080 |
Why?
|
Hamartoma Syndrome, Multiple | 3 | 1998 | 111 | 0.080 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2009 | 75 | 0.080 |
Why?
|
Equilibrative Nucleoside Transport Proteins | 1 | 2008 | 2 | 0.080 |
Why?
|
Pyrazines | 1 | 2015 | 1230 | 0.080 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2011 | 338 | 0.080 |
Why?
|
Eye Neoplasms | 1 | 1991 | 312 | 0.080 |
Why?
|
NIH 3T3 Cells | 2 | 2007 | 676 | 0.080 |
Why?
|
Threonine | 2 | 2007 | 279 | 0.080 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2013 | 789 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1404 | 0.080 |
Why?
|
Heterochromatin | 1 | 2011 | 296 | 0.080 |
Why?
|
Middle Aged | 25 | 2015 | 213241 | 0.080 |
Why?
|
Retinoblastoma | 1 | 1991 | 316 | 0.080 |
Why?
|
DNA Fragmentation | 1 | 2008 | 240 | 0.080 |
Why?
|
Cells, Cultured | 8 | 2011 | 19232 | 0.080 |
Why?
|
Cloning, Molecular | 7 | 2002 | 4320 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2008 | 203 | 0.080 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2007 | 92 | 0.080 |
Why?
|
Cell Death | 2 | 2015 | 1705 | 0.080 |
Why?
|
Tight Junctions | 1 | 2010 | 311 | 0.070 |
Why?
|
Tumor Suppressor Protein p14ARF | 2 | 1997 | 90 | 0.070 |
Why?
|
Kidney Glomerulus | 2 | 2001 | 697 | 0.070 |
Why?
|
Prostate | 1 | 2015 | 1763 | 0.070 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2007 | 245 | 0.070 |
Why?
|
Cell Differentiation | 7 | 2016 | 11478 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2008 | 1723 | 0.070 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2009 | 379 | 0.070 |
Why?
|
Tetracycline | 2 | 1997 | 214 | 0.070 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 1120 | 0.070 |
Why?
|
Cell Polarity | 1 | 2010 | 645 | 0.070 |
Why?
|
Genes, abl | 1 | 2006 | 72 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2005 | 9239 | 0.070 |
Why?
|
Piperazines | 2 | 2014 | 2487 | 0.070 |
Why?
|
Peritoneal Neoplasms | 2 | 2003 | 665 | 0.070 |
Why?
|
Aged | 21 | 2015 | 163178 | 0.070 |
Why?
|
Early Growth Response Protein 1 | 2 | 1997 | 138 | 0.070 |
Why?
|
Breast Neoplasms, Male | 1 | 2008 | 210 | 0.070 |
Why?
|
RNA Precursors | 1 | 2007 | 209 | 0.070 |
Why?
|
DNA, Complementary | 4 | 2007 | 2050 | 0.070 |
Why?
|
ras Proteins | 1 | 2012 | 1059 | 0.070 |
Why?
|
Mammary Tumor Virus, Mouse | 1 | 2006 | 61 | 0.070 |
Why?
|
Antigens, Surface | 1 | 2011 | 1663 | 0.070 |
Why?
|
Adenoviridae | 2 | 2002 | 1100 | 0.070 |
Why?
|
Sirolimus | 1 | 2013 | 1565 | 0.070 |
Why?
|
Podocytes | 1 | 2010 | 396 | 0.070 |
Why?
|
Fetus | 1 | 2013 | 1880 | 0.070 |
Why?
|
Rhabdomyosarcoma | 1 | 2009 | 384 | 0.070 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2008 | 323 | 0.070 |
Why?
|
beta Catenin | 2 | 2012 | 1060 | 0.070 |
Why?
|
Blotting, Western | 4 | 2002 | 5179 | 0.070 |
Why?
|
Antigens, CD | 2 | 2015 | 4026 | 0.070 |
Why?
|
Prevalence | 5 | 2009 | 15211 | 0.070 |
Why?
|
Databases, Genetic | 1 | 2012 | 1782 | 0.070 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 1998 | 535 | 0.070 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 2003 | 1085 | 0.060 |
Why?
|
Stem Cells | 3 | 2009 | 3566 | 0.060 |
Why?
|
Survival Analysis | 3 | 2013 | 10251 | 0.060 |
Why?
|
STAT5 Transcription Factor | 2 | 2004 | 259 | 0.060 |
Why?
|
Aminoquinolines | 1 | 2005 | 109 | 0.060 |
Why?
|
Cyclin E | 2 | 2005 | 172 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1988 | 0.060 |
Why?
|
Carcinoma in Situ | 1 | 2011 | 805 | 0.060 |
Why?
|
Aged, 80 and over | 9 | 2015 | 57744 | 0.060 |
Why?
|
Epidermal Growth Factor | 2 | 2005 | 709 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2938 | 0.060 |
Why?
|
Cisplatin | 2 | 2008 | 1662 | 0.060 |
Why?
|
DNA Repair | 3 | 2011 | 2045 | 0.060 |
Why?
|
Organic Chemicals | 1 | 2005 | 210 | 0.060 |
Why?
|
Enzyme Activation | 4 | 2011 | 3701 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2005 | 1861 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2110 | 0.060 |
Why?
|
Embryo, Nonmammalian | 1 | 2007 | 895 | 0.060 |
Why?
|
Treatment Outcome | 12 | 2016 | 63042 | 0.060 |
Why?
|
Cyclophosphamide | 1 | 2010 | 2241 | 0.060 |
Why?
|
Head and Neck Neoplasms | 2 | 2010 | 2736 | 0.060 |
Why?
|
src-Family Kinases | 1 | 2006 | 551 | 0.060 |
Why?
|
Clinical Trials as Topic | 3 | 2011 | 7908 | 0.060 |
Why?
|
Macromolecular Substances | 3 | 1998 | 1454 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2010 | 6539 | 0.060 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 1996 | 657 | 0.060 |
Why?
|
Community Health Services | 2 | 1999 | 650 | 0.060 |
Why?
|
Mutagenesis | 2 | 1999 | 1263 | 0.060 |
Why?
|
Biopsy | 1 | 2015 | 6750 | 0.060 |
Why?
|
HeLa Cells | 2 | 2015 | 3130 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2001 | 10179 | 0.060 |
Why?
|
Metabolic Networks and Pathways | 1 | 2008 | 783 | 0.060 |
Why?
|
Diptera | 1 | 2003 | 53 | 0.060 |
Why?
|
Membrane Glycoproteins | 3 | 2003 | 3769 | 0.060 |
Why?
|
Adenosine | 1 | 2008 | 825 | 0.060 |
Why?
|
Methionine | 1 | 2005 | 590 | 0.060 |
Why?
|
Two-Hybrid System Techniques | 1 | 2004 | 464 | 0.060 |
Why?
|
Diagnostic Tests, Routine | 1 | 2009 | 782 | 0.060 |
Why?
|
Hominidae | 1 | 2003 | 74 | 0.050 |
Why?
|
Genes, Helminth | 1 | 2003 | 147 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2014 | 1911 | 0.050 |
Why?
|
Hematopoiesis | 2 | 2003 | 2073 | 0.050 |
Why?
|
Genes | 3 | 1991 | 1893 | 0.050 |
Why?
|
Nucleic Acid Conformation | 1 | 2006 | 914 | 0.050 |
Why?
|
Receptors, Interleukin-15 | 1 | 2002 | 16 | 0.050 |
Why?
|
HEK293 Cells | 1 | 2012 | 4204 | 0.050 |
Why?
|
Pyrroles | 1 | 2009 | 1147 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2015 | 11524 | 0.050 |
Why?
|
Interleukin-2 Receptor beta Subunit | 1 | 2002 | 24 | 0.050 |
Why?
|
Karyotyping | 4 | 2007 | 1243 | 0.050 |
Why?
|
Protein Transport | 2 | 2008 | 1988 | 0.050 |
Why?
|
Genes, cdc | 1 | 2002 | 116 | 0.050 |
Why?
|
Saccharomyces cerevisiae | 3 | 2004 | 2750 | 0.050 |
Why?
|
Yeasts | 1 | 2003 | 284 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2010 | 4033 | 0.050 |
Why?
|
Receptors, Purinergic P2 | 1 | 2003 | 153 | 0.050 |
Why?
|
Janus Kinase 3 | 1 | 2002 | 78 | 0.050 |
Why?
|
Janus Kinase 1 | 1 | 2002 | 104 | 0.050 |
Why?
|
Models, Molecular | 4 | 2006 | 5445 | 0.050 |
Why?
|
Estrogen Antagonists | 1 | 2002 | 151 | 0.050 |
Why?
|
Mitosis | 2 | 2004 | 1207 | 0.050 |
Why?
|
Phylogeny | 3 | 2004 | 2796 | 0.050 |
Why?
|
Computer Simulation | 1 | 2015 | 6188 | 0.050 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2002 | 300 | 0.050 |
Why?
|
Mitochondria | 1 | 2014 | 3513 | 0.050 |
Why?
|
beta-Galactosidase | 1 | 2002 | 574 | 0.050 |
Why?
|
Fallopian Tubes | 1 | 2002 | 182 | 0.050 |
Why?
|
Fibromatosis, Abdominal | 1 | 2001 | 24 | 0.050 |
Why?
|
Interleukin-5 | 1 | 2002 | 273 | 0.050 |
Why?
|
Structure-Activity Relationship | 2 | 2006 | 3128 | 0.050 |
Why?
|
Histiocytosis, Non-Langerhans-Cell | 1 | 2001 | 20 | 0.050 |
Why?
|
Arylsulfotransferase | 1 | 2000 | 28 | 0.050 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 1981 | 142 | 0.050 |
Why?
|
Heart | 1 | 2014 | 4460 | 0.050 |
Why?
|
Adenovirus E1A Proteins | 1 | 2001 | 76 | 0.050 |
Why?
|
Biomedical Engineering | 2 | 2014 | 296 | 0.050 |
Why?
|
Down-Regulation | 2 | 2013 | 3000 | 0.050 |
Why?
|
Luminescent Proteins | 1 | 2004 | 853 | 0.050 |
Why?
|
Recombinant Proteins | 3 | 2001 | 6620 | 0.050 |
Why?
|
Gonads | 1 | 2001 | 109 | 0.050 |
Why?
|
Genetic Counseling | 3 | 2003 | 600 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 1213 | 0.050 |
Why?
|
Homozygote | 2 | 2003 | 1787 | 0.050 |
Why?
|
Surface Properties | 2 | 2015 | 1168 | 0.050 |
Why?
|
CREB-Binding Protein | 1 | 2001 | 151 | 0.050 |
Why?
|
Xenopus | 1 | 2002 | 712 | 0.050 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1988 | 1381 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 3 | 2004 | 3772 | 0.050 |
Why?
|
Mesenchymal Stem Cells | 1 | 2011 | 1632 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 3645 | 0.050 |
Why?
|
Prognosis | 5 | 2015 | 29052 | 0.050 |
Why?
|
Receptors, Interleukin-2 | 1 | 2002 | 573 | 0.050 |
Why?
|
Abdominal Neoplasms | 1 | 2002 | 292 | 0.050 |
Why?
|
RNA Helicases | 1 | 2001 | 142 | 0.050 |
Why?
|
Aniline Compounds | 1 | 2005 | 986 | 0.050 |
Why?
|
Histones | 2 | 2011 | 2598 | 0.050 |
Why?
|
HLA-DQ Antigens | 1 | 2000 | 210 | 0.050 |
Why?
|
Testis | 3 | 1999 | 795 | 0.050 |
Why?
|
Restriction Mapping | 3 | 1996 | 878 | 0.050 |
Why?
|
Flow Cytometry | 4 | 2015 | 5973 | 0.050 |
Why?
|
Chemotaxis | 1 | 2003 | 607 | 0.050 |
Why?
|
Fishes | 1 | 2003 | 569 | 0.050 |
Why?
|
Sulfonamides | 3 | 2015 | 1938 | 0.050 |
Why?
|
Neuroblastoma | 1 | 2008 | 1226 | 0.050 |
Why?
|
Gastrointestinal Neoplasms | 1 | 1988 | 991 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2003 | 449 | 0.040 |
Why?
|
Cell Count | 2 | 2015 | 1855 | 0.040 |
Why?
|
Gene Library | 3 | 1999 | 1074 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2011 | 14563 | 0.040 |
Why?
|
Genomic Imprinting | 1 | 2001 | 331 | 0.040 |
Why?
|
Mosaicism | 1 | 2002 | 441 | 0.040 |
Why?
|
DNA Footprinting | 1 | 1999 | 98 | 0.040 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2000 | 351 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2003 | 1862 | 0.040 |
Why?
|
Yoga | 1 | 1983 | 252 | 0.040 |
Why?
|
Postmenopause | 1 | 2008 | 2458 | 0.040 |
Why?
|
Carcinoma, Lobular | 1 | 2003 | 484 | 0.040 |
Why?
|
Lymphoma | 1 | 2008 | 1875 | 0.040 |
Why?
|
Peptide Chain Termination, Translational | 1 | 1998 | 28 | 0.040 |
Why?
|
Rad51 Recombinase | 1 | 1999 | 189 | 0.040 |
Why?
|
Luciferases | 1 | 2001 | 733 | 0.040 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 1520 | 0.040 |
Why?
|
Drug Synergism | 2 | 2015 | 1794 | 0.040 |
Why?
|
HLA-DR Antigens | 1 | 2000 | 645 | 0.040 |
Why?
|
Enzyme Induction | 1 | 1999 | 475 | 0.040 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 1999 | 323 | 0.040 |
Why?
|
Sex Education | 1 | 1999 | 93 | 0.040 |
Why?
|
Keratinocytes | 1 | 2002 | 796 | 0.040 |
Why?
|
Green Fluorescent Proteins | 1 | 2004 | 2086 | 0.040 |
Why?
|
Ataxia Telangiectasia | 1 | 1999 | 112 | 0.040 |
Why?
|
Child, Preschool | 9 | 2013 | 40964 | 0.040 |
Why?
|
Pseudogenes | 1 | 1998 | 113 | 0.040 |
Why?
|
Cohort Studies | 8 | 2013 | 40545 | 0.040 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 1998 | 80 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2004 | 902 | 0.040 |
Why?
|
Urban Health Services | 1 | 1999 | 179 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2013 | 4251 | 0.040 |
Why?
|
Chromosome Aberrations | 3 | 1994 | 1811 | 0.040 |
Why?
|
STAT3 Transcription Factor | 1 | 2002 | 873 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 2002 | 969 | 0.040 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 1997 | 70 | 0.040 |
Why?
|
Genetic Linkage | 3 | 1998 | 2419 | 0.040 |
Why?
|
Survival Rate | 3 | 2008 | 12786 | 0.040 |
Why?
|
DNA Repair Enzymes | 1 | 1999 | 349 | 0.040 |
Why?
|
Founder Effect | 1 | 1998 | 189 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 452 | 0.040 |
Why?
|
Leucine Zippers | 1 | 1997 | 117 | 0.040 |
Why?
|
Molecular Biology | 2 | 1998 | 595 | 0.040 |
Why?
|
Inclusion Bodies | 1 | 1998 | 279 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2001 | 1545 | 0.040 |
Why?
|
Ureter | 1 | 1999 | 375 | 0.040 |
Why?
|
Adolescent Health Services | 1 | 1999 | 215 | 0.040 |
Why?
|
Culture Techniques | 1 | 1977 | 553 | 0.040 |
Why?
|
Cell Transformation, Viral | 1 | 1998 | 566 | 0.040 |
Why?
|
Hodgkin Disease | 2 | 1999 | 1415 | 0.040 |
Why?
|
Genes, APC | 1 | 1997 | 158 | 0.040 |
Why?
|
Blastocyst | 1 | 1999 | 424 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2010 | 893 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1997 | 365 | 0.030 |
Why?
|
Pyrimidines | 1 | 2008 | 2945 | 0.030 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2003 | 1100 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6773 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2003 | 1222 | 0.030 |
Why?
|
Molecular Weight | 1 | 1998 | 2253 | 0.030 |
Why?
|
Microtubules | 1 | 2001 | 1087 | 0.030 |
Why?
|
Hexuronic Acids | 1 | 2015 | 144 | 0.030 |
Why?
|
Glucuronic Acid | 1 | 2015 | 148 | 0.030 |
Why?
|
Telomeric Repeat Binding Protein 2 | 1 | 2015 | 18 | 0.030 |
Why?
|
Centrifugation | 1 | 2015 | 122 | 0.030 |
Why?
|
School Health Services | 1 | 1999 | 375 | 0.030 |
Why?
|
Carbanilides | 1 | 2014 | 17 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2002 | 2692 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1999 | 912 | 0.030 |
Why?
|
Replication Protein A | 1 | 2015 | 52 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2016 | 403 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2002 | 1904 | 0.030 |
Why?
|
gamma Catenin | 1 | 2014 | 44 | 0.030 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 1999 | 547 | 0.030 |
Why?
|
Polyamines | 1 | 2015 | 120 | 0.030 |
Why?
|
Temperature | 2 | 2015 | 2202 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2001 | 1702 | 0.030 |
Why?
|
Genome | 1 | 2003 | 1806 | 0.030 |
Why?
|
Patient Selection | 1 | 2007 | 4210 | 0.030 |
Why?
|
Time Factors | 5 | 2008 | 40038 | 0.030 |
Why?
|
Recombination, Genetic | 1 | 1999 | 1586 | 0.030 |
Why?
|
Sex Factors | 1 | 2008 | 10394 | 0.030 |
Why?
|
Child | 12 | 2005 | 77637 | 0.030 |
Why?
|
Transforming Growth Factor beta | 2 | 2013 | 2006 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2005 | 3038 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2001 | 2712 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 1998 | 820 | 0.030 |
Why?
|
Histidine | 2 | 2007 | 312 | 0.030 |
Why?
|
Ribosomal Protein S6 | 1 | 2013 | 70 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12354 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2010 | 1374 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2002 | 3205 | 0.030 |
Why?
|
Oligonucleotide Probes | 2 | 1991 | 427 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2006 | 9731 | 0.030 |
Why?
|
Neoplasms, Experimental | 2 | 2015 | 1272 | 0.030 |
Why?
|
Syndrome | 5 | 1999 | 3249 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2001 | 2509 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1993 | 278 | 0.030 |
Why?
|
Gelatin | 1 | 2015 | 226 | 0.030 |
Why?
|
Paclitaxel | 2 | 2016 | 1705 | 0.030 |
Why?
|
Genetic Vectors | 2 | 2001 | 3421 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 1996 | 539 | 0.030 |
Why?
|
Adenovirus Early Proteins | 1 | 1992 | 57 | 0.030 |
Why?
|
Retreatment | 1 | 2014 | 609 | 0.030 |
Why?
|
Glioma | 2 | 2015 | 3401 | 0.030 |
Why?
|
Monophenol Monooxygenase | 1 | 2012 | 69 | 0.030 |
Why?
|
Chromatography, Gel | 1 | 1993 | 670 | 0.030 |
Why?
|
Receptor, Melanocortin, Type 1 | 1 | 2012 | 76 | 0.030 |
Why?
|
Insect Proteins | 1 | 2014 | 255 | 0.030 |
Why?
|
Risk Factors | 6 | 2007 | 72252 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2002 | 2037 | 0.030 |
Why?
|
Peroxidases | 1 | 2012 | 138 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2008 | 10940 | 0.030 |
Why?
|
Photoreceptor Cells, Invertebrate | 2 | 2002 | 39 | 0.030 |
Why?
|
Violence | 1 | 1999 | 909 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2010 | 19894 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2014 | 8637 | 0.030 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2008 | 3524 | 0.030 |
Why?
|
Larva | 2 | 2004 | 515 | 0.030 |
Why?
|
Abnormalities, Multiple | 1 | 1999 | 1416 | 0.030 |
Why?
|
Fibroblasts | 1 | 2002 | 4162 | 0.030 |
Why?
|
Carbohydrate Sequence | 1 | 2012 | 414 | 0.030 |
Why?
|
Prostate-Specific Antigen | 2 | 2013 | 2471 | 0.030 |
Why?
|
Causality | 1 | 1998 | 1275 | 0.030 |
Why?
|
Tyrosine | 2 | 2007 | 1462 | 0.030 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2012 | 105 | 0.030 |
Why?
|
Germ-Free Life | 1 | 2012 | 188 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2010 | 1660 | 0.030 |
Why?
|
Genitalia, Male | 1 | 1991 | 84 | 0.030 |
Why?
|
Gene Dosage | 1 | 2016 | 1252 | 0.030 |
Why?
|
Oligonucleotides | 2 | 1991 | 572 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2014 | 535 | 0.020 |
Why?
|
Monocytes | 1 | 2001 | 2593 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2002 | 3082 | 0.020 |
Why?
|
Materials Testing | 1 | 2015 | 866 | 0.020 |
Why?
|
Genes, erbB-2 | 1 | 2011 | 162 | 0.020 |
Why?
|
Aspartic Acid | 1 | 1993 | 576 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 1998 | 975 | 0.020 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2012 | 188 | 0.020 |
Why?
|
Multigene Family | 2 | 1998 | 1101 | 0.020 |
Why?
|
Cell Size | 1 | 2013 | 641 | 0.020 |
Why?
|
Research Design | 1 | 2007 | 5983 | 0.020 |
Why?
|
Orchiectomy | 1 | 2013 | 468 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 1998 | 1781 | 0.020 |
Why?
|
Radiation, Ionizing | 1 | 2011 | 258 | 0.020 |
Why?
|
Melanins | 1 | 2012 | 289 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 623 | 0.020 |
Why?
|
Suppression, Genetic | 1 | 1991 | 196 | 0.020 |
Why?
|
Computer Graphics | 1 | 2012 | 360 | 0.020 |
Why?
|
Chromosome Banding | 3 | 1998 | 278 | 0.020 |
Why?
|
Health Promotion | 1 | 1983 | 2205 | 0.020 |
Why?
|
Deoxyribonuclease HpaII | 1 | 1989 | 16 | 0.020 |
Why?
|
Acute Disease | 1 | 2001 | 7150 | 0.020 |
Why?
|
Glycine | 1 | 1993 | 670 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2007 | 9944 | 0.020 |
Why?
|
Ligands | 2 | 2009 | 3281 | 0.020 |
Why?
|
Animals, Newborn | 1 | 1995 | 2725 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1094 | 0.020 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1989 | 170 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2014 | 1233 | 0.020 |
Why?
|
Retroperitoneal Neoplasms | 1 | 1993 | 340 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 944 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2015 | 1684 | 0.020 |
Why?
|
Eye | 2 | 2004 | 727 | 0.020 |
Why?
|
Sequence Alignment | 3 | 1999 | 2256 | 0.020 |
Why?
|
Sexual Behavior | 1 | 1999 | 2049 | 0.020 |
Why?
|
Neoplasm Staging | 3 | 2009 | 11036 | 0.020 |
Why?
|
Students | 1 | 1999 | 1647 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2718 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2014 | 973 | 0.020 |
Why?
|
Fathers | 1 | 1991 | 358 | 0.020 |
Why?
|
Oncogene Protein v-akt | 1 | 2008 | 135 | 0.020 |
Why?
|
Immunoproliferative Small Intestinal Disease | 1 | 1988 | 4 | 0.020 |
Why?
|
Treatment Failure | 1 | 2014 | 2617 | 0.020 |
Why?
|
RNA Caps | 1 | 1988 | 74 | 0.020 |
Why?
|
Protein Structure, Secondary | 2 | 2003 | 1245 | 0.020 |
Why?
|
Sarcoma | 1 | 1999 | 1898 | 0.020 |
Why?
|
Risk | 2 | 1998 | 9677 | 0.020 |
Why?
|
Isoleucine | 1 | 2007 | 112 | 0.020 |
Why?
|
Hawaii | 1 | 2007 | 105 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 674 | 0.020 |
Why?
|
Leukocytes | 1 | 2016 | 2044 | 0.020 |
Why?
|
Globins | 1 | 1988 | 416 | 0.020 |
Why?
|
Carcinoma, Large Cell | 1 | 2008 | 113 | 0.020 |
Why?
|
Tissue Scaffolds | 1 | 2014 | 956 | 0.020 |
Why?
|
Receptor, erbB-3 | 1 | 2008 | 142 | 0.020 |
Why?
|
Molecular Structure | 1 | 2012 | 1894 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6356 | 0.020 |
Why?
|
Cytogenetic Analysis | 1 | 2008 | 294 | 0.020 |
Why?
|
Digestive System | 1 | 1988 | 253 | 0.020 |
Why?
|
Spodoptera | 1 | 2007 | 153 | 0.020 |
Why?
|
Baculoviridae | 1 | 2007 | 118 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 2000 | 2282 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 480 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2012 | 838 | 0.020 |
Why?
|
New York City | 2 | 1999 | 705 | 0.020 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2008 | 334 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3574 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 489 | 0.020 |
Why?
|
Erythrocytes | 1 | 2016 | 2455 | 0.020 |
Why?
|
Leucine | 1 | 2007 | 559 | 0.020 |
Why?
|
Pregnancy | 2 | 2006 | 29140 | 0.020 |
Why?
|
Proline | 1 | 2007 | 457 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2014 | 1631 | 0.020 |
Why?
|
Phosphotransferases | 1 | 2007 | 308 | 0.020 |
Why?
|
Lymphokines | 1 | 2009 | 948 | 0.020 |
Why?
|
Prospective Studies | 2 | 2008 | 53250 | 0.020 |
Why?
|
Finland | 1 | 2007 | 602 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 1991 | 1179 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2013 | 1582 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2010 | 1083 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2010 | 1073 | 0.020 |
Why?
|
Transforming Growth Factor alpha | 1 | 2005 | 135 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2007 | 500 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 738 | 0.020 |
Why?
|
Neurons | 1 | 2004 | 9336 | 0.020 |
Why?
|
Caco-2 Cells | 1 | 2005 | 388 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2009 | 1098 | 0.020 |
Why?
|
Haplotypes | 2 | 2004 | 2779 | 0.020 |
Why?
|
Infant | 6 | 2001 | 35122 | 0.010 |
Why?
|
Mastectomy, Simple | 1 | 2003 | 24 | 0.010 |
Why?
|
ADP-ribosyl Cyclase | 1 | 2003 | 38 | 0.010 |
Why?
|
Aging | 1 | 1983 | 8655 | 0.010 |
Why?
|
Receptors, Purinergic P2Y | 1 | 2003 | 25 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2012 | 2378 | 0.010 |
Why?
|
Cosmids | 2 | 1996 | 107 | 0.010 |
Why?
|
Endometrial Neoplasms | 1 | 1993 | 1350 | 0.010 |
Why?
|
X-Rays | 1 | 2004 | 301 | 0.010 |
Why?
|
Pyridones | 1 | 2008 | 711 | 0.010 |
Why?
|
Neutrophils | 1 | 2016 | 3718 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2008 | 2556 | 0.010 |
Why?
|
Chickens | 1 | 2005 | 864 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2004 | 644 | 0.010 |
Why?
|
Physical Chromosome Mapping | 1 | 2003 | 183 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2009 | 14714 | 0.010 |
Why?
|
Benzimidazoles | 1 | 2008 | 850 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2007 | 1802 | 0.010 |
Why?
|
Intestinal Neoplasms | 1 | 2005 | 319 | 0.010 |
Why?
|
Administration, Oral | 1 | 2010 | 3912 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2015 | 3587 | 0.010 |
Why?
|
Interferon Regulatory Factor-7 | 1 | 2002 | 39 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2004 | 960 | 0.010 |
Why?
|
Clone Cells | 2 | 1994 | 1692 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2004 | 697 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2003 | 537 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2010 | 1707 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 1988 | 2879 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 2003 | 658 | 0.010 |
Why?
|
COS Cells | 1 | 2003 | 1161 | 0.010 |
Why?
|
Israel | 1 | 2004 | 796 | 0.010 |
Why?
|
United States | 3 | 2013 | 69859 | 0.010 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2001 | 100 | 0.010 |
Why?
|
Antibodies | 1 | 2009 | 2459 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2006 | 77410 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2000 | 335 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3058 | 0.010 |
Why?
|
Eye Abnormalities | 1 | 2002 | 246 | 0.010 |
Why?
|
Blotting, Southern | 2 | 1991 | 803 | 0.010 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2001 | 277 | 0.010 |
Why?
|
Central Nervous System Neoplasms | 1 | 2008 | 895 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2005 | 988 | 0.010 |
Why?
|
Foot Deformities, Congenital | 1 | 1999 | 59 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2001 | 437 | 0.010 |
Why?
|
DNA Probes | 2 | 1991 | 560 | 0.010 |
Why?
|
Fertility | 1 | 2004 | 779 | 0.010 |
Why?
|
Vincristine | 1 | 2001 | 1039 | 0.010 |
Why?
|
Premenopause | 1 | 2003 | 1033 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1988 | 2232 | 0.010 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2003 | 710 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 1997 | 7172 | 0.010 |
Why?
|
Ectodermal Dysplasia | 1 | 1999 | 106 | 0.010 |
Why?
|
Hand Deformities, Congenital | 1 | 1999 | 146 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2001 | 936 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2003 | 1880 | 0.010 |
Why?
|
Family | 1 | 2009 | 3144 | 0.010 |
Why?
|
Chromosomes | 1 | 1981 | 596 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 1999 | 791 | 0.010 |
Why?
|
Adolescent | 5 | 2014 | 85729 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 1998 | 5691 | 0.010 |
Why?
|
Benzopyrenes | 1 | 1977 | 5 | 0.010 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2001 | 623 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2008 | 6895 | 0.010 |
Why?
|
HL-60 Cells | 1 | 1998 | 365 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 2001 | 733 | 0.010 |
Why?
|
Arginine | 1 | 2000 | 943 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2007 | 21733 | 0.010 |
Why?
|
Selection, Genetic | 1 | 1981 | 914 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2004 | 2190 | 0.010 |
Why?
|
ROC Curve | 1 | 2004 | 3527 | 0.010 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 1996 | 118 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2004 | 3617 | 0.010 |
Why?
|
Follow-Up Studies | 3 | 2006 | 39001 | 0.010 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1999 | 547 | 0.010 |
Why?
|
Pilot Projects | 1 | 2009 | 8316 | 0.010 |
Why?
|
Tissue Distribution | 2 | 1991 | 2327 | 0.010 |
Why?
|
Astrocytoma | 1 | 2000 | 790 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2004 | 2504 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3503 | 0.010 |
Why?
|
Germany | 1 | 1998 | 862 | 0.010 |
Why?
|
Codon | 1 | 1997 | 611 | 0.010 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2001 | 570 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 1999 | 1793 | 0.010 |
Why?
|
Risk Assessment | 2 | 2007 | 23327 | 0.010 |
Why?
|
Cell Lineage | 1 | 2003 | 2506 | 0.010 |
Why?
|
Random Allocation | 1 | 1999 | 2429 | 0.010 |
Why?
|
Mammals | 1 | 1999 | 1143 | 0.010 |
Why?
|
Species Specificity | 1 | 1998 | 2480 | 0.010 |
Why?
|
Attitude to Health | 1 | 1983 | 2052 | 0.010 |
Why?
|
Face | 1 | 1999 | 993 | 0.010 |
Why?
|
Hemagglutinins, Viral | 1 | 1991 | 67 | 0.010 |
Why?
|
Herpesviridae Infections | 1 | 1993 | 277 | 0.010 |
Why?
|
Gene Products, tat | 1 | 1991 | 120 | 0.010 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 1991 | 127 | 0.010 |
Why?
|
Urban Population | 1 | 1999 | 2021 | 0.010 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1991 | 157 | 0.010 |
Why?
|
Program Evaluation | 1 | 1999 | 2483 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1990 | 441 | 0.010 |
Why?
|
Health Status | 1 | 1983 | 4031 | 0.010 |
Why?
|
Protein Conformation | 1 | 1997 | 4009 | 0.010 |
Why?
|
Logistic Models | 1 | 2004 | 13404 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1991 | 510 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1991 | 1826 | 0.010 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1991 | 494 | 0.010 |
Why?
|
Young Adult | 1 | 2014 | 56392 | 0.000 |
Why?
|
Cell-Free System | 1 | 1988 | 344 | 0.000 |
Why?
|
Boston | 1 | 2001 | 9310 | 0.000 |
Why?
|
Herpesvirus 4, Human | 1 | 1993 | 1041 | 0.000 |
Why?
|
Liver | 1 | 2003 | 7479 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2007 | 25609 | 0.000 |
Why?
|
Uterus | 1 | 1991 | 711 | 0.000 |
Why?
|
Blood Pressure | 1 | 1983 | 8551 | 0.000 |
Why?
|
Poverty | 1 | 1999 | 2660 | 0.000 |
Why?
|
Ovary | 1 | 1991 | 980 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 2001 | 12954 | 0.000 |
Why?
|
Curriculum | 1 | 1999 | 3603 | 0.000 |
Why?
|
Recurrence | 1 | 1996 | 8337 | 0.000 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 1999 | 3921 | 0.000 |
Why?
|
HIV | 1 | 1991 | 1604 | 0.000 |
Why?
|
Lymphocytes | 1 | 1991 | 2615 | 0.000 |
Why?
|
Rabbits | 1 | 1988 | 4894 | 0.000 |
Why?
|
Age Factors | 1 | 1996 | 18355 | 0.000 |
Why?
|